Home>>Signaling Pathways>> Cell Cycle/Checkpoint>> Proteolysis>>Dabcyl-GABA-PQGL-Glu(EDANS)-AK-NH2, (trifluoroacetate salt)

Dabcyl-GABA-PQGL-Glu(EDANS)-AK-NH2, (trifluoroacetate salt) (Synonyms: MMP Fluorogenic Substrate III)

Catalog No.GC47164

A neuropeptide with diverse biological activities

Products are for research use only. Not for human use. We do not sell to patients.

Dabcyl-GABA-PQGL-Glu(EDANS)-AK-NH2, (trifluoroacetate salt) Chemical Structure

Cas No.: N/A

Size Price Stock Qty
500 μg
$461.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Dabcyl-GABA-PQGL-Glu(EDANS)-AK-NH2 is a fluorogenic substrate for matrix metalloproteinase-1 (MMP-1), MMP-2, MMP-3, and MMP-9.1 Upon enzymatic cleavage by MMP-1, MMP-2, MMP-3, or MMP-9 at the Gly-Leu site, EDANS is separated from the Dabcyl quencher and its fluorescence can be used to quantify MMP-1, MMP-2, MMP-3, and MMP-9 activity.1,2 EDANS displays excitation/emission maxima of 340/485 nm, respectively.

1.Beekman, B., Drijfhout, J.W., Bloemhoff, W., et al.Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological mediaFEBS Lett.390(2)221-225(1996) 2.Krismastuti, F.S.H., Pace, S., and Voelcker, N.H.Porous silicon resonant microcavity biosensor for matrix metalloproteinase detectionAdv. Funct. Mater.24(23)3639-3650(2014)

Reviews

Review for Dabcyl-GABA-PQGL-Glu(EDANS)-AK-NH2, (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 13 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Dabcyl-GABA-PQGL-Glu(EDANS)-AK-NH2, (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.